1 results match your criteria: "España. asanso@hospitalmanacor.org[Affiliation]"
[Ustekinumab in a patient with Crohn's disease and anti-TNF-α-induced psoriasis].
Gastroenterol Hepatol
October 2011
Servicio de Digestivo, Hospital de Manacor, Manacor, Baleares, España.
Article Synopsis
- Treatment with anti-TNF-α for Crohn's disease is generally safe, but can cause skin issues like psoriasis, which may lead to discontinuation of the treatment.
- Ustekinumab, a new treatment targeting interleukin 12/23, shows promise for Crohn's disease and psoriasis.
- A case study illustrates a woman who developed psoriasis after two anti-TNF treatments but successfully managed both conditions with ustekinumab.